- Home
- NEA vs LGND Comparison
NEA vs LGND Comparison
Compare NEA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEA | LGND |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | NEA | LGND |
|---|---|---|
| Price | $11.57 | $199.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $144.71 |
| AVG Volume (30 Days) | ★ 803.4K | 139.7K |
| Earning Date | 01-01-0001 | 08-05-2025 |
| Dividend Yield | ★ 4.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,488,000.00 |
| Revenue This Year | N/A | $18.41 |
| Revenue Next Year | N/A | $18.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.40 |
| 52 Week Low | $9.20 | $81.74 |
| 52 Week High | $11.37 | $129.90 |
Technical Indicators
Market Signals| Indicator | NEA | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 57.72 |
| Support Level | $11.45 | $188.69 |
| Resistance Level | $11.65 | $192.44 |
| Average True Range (ATR) | 0.09 | 6.37 |
| MACD | -0.00 | 0.70 |
| Stochastic Oscillator | 47.16 | 85.03 |
Price Performance
Historical ComparisonAbout NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.